In the years since the first guidance for clinical laboratories, the Department
of Health and Human Services Office of Inspector General (OIG) has issued many,
many formal compliance guidance documents, along with special fraud alerts,
advisory bulletins and opinions, and open letters.
It’s a bewildering array of documents about practices that could be considered
questionable or illegal. It’s especially confusing to new staff being
introduced to compliance for the first time.
Now, Washington G2 Reports has revised and updated its previous edition of the
G-2 Compliance Resource Guide, an unrivalled resource essential
to developing, implementing, and monitoring of your compliance programs.
This new 350+ page report covers key materials issued or published in the last
two years, including:
I. OIG Guidance & Advisories. Medicare Part D patient
assistance programs, safe harbors for electronic health records technology,
the OIG’s Supplemental Compliance Program Guidance for Hospitals, summaries
of the Stark Law, the Stark Master Code List for 2007, and OIG advisory opinions
since January 2005.
II. False Claims Act. Government intervention in whistleblower
suits, FCA settlements in 2005-06, articles on the False Claims Act, plus coverage
of state False Claims Acts and OIG guidelines for evaluating them.
III. HIPAA. The status of HIPAA regulations
and summaries of key HIPAA provisions, enforcement guidance, the final rule
on implementation of the National Provider Identifier, and the contingency plan
for NPI compliance.
IV. Special Concerns for Labs. The new proposed Advance Beneficiary
Notice, changes to independent lab billing for the technical component of physician
pathology services, FDA guidance on in-vitro diagnostic multivariate index assays
(IVDMIAs), and the OIG’s advisory opinion on pod laboratories.
Preview this report's Introduction and Table of Contents.
